Please login first

Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine

26–27 Nov 2020, Novosibirsk, Russia

Genomic Research In Endocrinology, Epidemiology and Pathogenesis of Endocrine Disorders, Metabolomic Research In Endocrinology
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Contact Us Become a Sponsor
DEAR COLLEAGUES!
You are invited to take part in the all-Russian conference with international participation “Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine".
The purpose of this conference is to make a wide spectrum of specialists aware of the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of endocrine disorders.
The conference will include plenary sessions, specialty sessions, and an educational course for physicians: “Maturity Onset Diabetes of the Young (MODY): Molecular Genetic Determinants and a Personalized Approach to Patient Management.”

Welcome from the Chairs

You are invited to take part in the all-Russian conference with international participation “Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine,” which will be held in Novosibirsk, 26–27 November 2020. The purpose of this conference is to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of endocrine disorders among a wide spectrum of specialists. The conference will include plenary sessions, specialty sessions, satellite symposia, and an open competition for young scientists.
The materials of the conference “Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine” will be published in special issue of international Journal of Personalized Medicine (the journal of the publishing house MDPI) indexed in Scopus, Web of Science, etc.: https://www.mdpi.com/journal/jpm/special_issues/Endocrinology_Russia

Conference Organizers

Internal and Preventive Medicine (IIPM) – a branch of the Institute of Cytology and Genetics (ICG), the Siberian Branch of the Russian Academy of Sciences (SB RAS), Novosibirsk

IIPM – a branch of the ICG SB RAS, the federal research center ICG SB RAS,
The Federal research center ICG SB RAS

DETAILS
Introduction

We organize the conference with international participation “Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine,” which will be held in Novosibirsk, Russia, 26–27 November 2020.

The purpose of this conference is to make a wide spectrum of specialists aware of the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of endocrine disorders.

The conference is addressed to physician–endocrinologists, primary care physicians, medical geneticists, pediatric endocrinologists, pediatricians, and physician–scientists.

The conference will include plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists, and an educational course for physicians: “Maturity Onset Diabetes of the Young (MODY): Molecular Genetic Determinants and a Personalized Approach to Patient Management.”

Program Committee Chair: Mikhail Voevoda, member of the Russian Academy of Sciences, professor, Ph.D., M.D., Sc.D.

Organizers: IIPM – a branch of the ICG SB RAS (www.iimed.ru) and the Federal Research Center ICG SB RAS (http://www.bionet.nsc.ru)

Conference languages: Russian and English

All interested specialists are invited to participate in the conference.

VENUE:
House of Scientists (Dom Uchenykh) SB RAS, 23 Morskoy Prospekt, Akademgorodok, Novosibirsk

Dates:
Abstracts are accepted until 10 September 2020
Online registration deadline: 25 November 2020
On-site registration: 26–27 November 2020

Conference Chairs

The Institute of Internal and Preventive Medicine (IIPM) – a branch of the Institute of Cytology and Genetics (ICG), the Siberian Branch of the Russian Academy of Sciences (SB RAS), Novosibirsk (www.iimed.ru)

DETAILS
Bio
Voevoda Mikhail Ivanovich PhD and ScD in medicine, Main Accreditation Commission (VAK) professor, Russian Academy of Sciences (RAS) professor, academician of the RAS, head of the Federal Research Center for Basic and Translational Medicine Voevoda M.I. is an expert in the fields of the molecular and medical genetic and an author or coauthor of more than 800 scientific publications, including 13 books, 16 patents of the Russian Federation. In the Russian Scientific Citation Index (RSCI): 935 publications, 8414 citations, h-index: 35. In Scopus: 281 publications, 6578 citations, h-index: 23. In the Web of Science: 283 publications, 4429 citations, h-index: 21. In 1982, he graduated from Novosibirsk State Medical University. In 1990, he defended a PhD dissertation, and in 2001, an ScD dissertation. The main basic-research accomplishments of Voevoda M.I.: A study on the key on molecular biological, organism level, and populational patterns of development of major internal diseases in the Siberian population and designing a scientific basis for their prevention, diagnosis, and treatment. Voevoda M.I. supervises graduate courses in the Medical Genetics specialty and the Endocrinology specialty. Under him tutelage, 20 PhD dissertations and 10 ScD dissertations have been defended. M.I. Voevoda has been elected Deputy Chairman of the Presidium of the SB RAS Since 2017 (https://www.sbras.ru/en). He is a Member of the Council of the International Society of Therapists, Member of the Council of the International Society for Circumpolar Health, Vice-President of the Russian Society of Atherosclerosis. Voevoda M.I. is a member of the ICG SB RAS Scientific Council, the member of Thesis Committee Д.003.011.02. Voevoda M.I. is an executive Secretary of the Siberian Scientific Medical Journal, member of the editorial board of the Vavilov Journal of Genetics and Breeding, member of the editorial board of the journal Atheroscleroz (Russia), Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences, Russian Cardiology Journal, a

the Institute of Internal and Preventive Medicine (IIPM) – a branch of the Institute of Cytology and Genetics (ICG), the Siberian Branch of the Russian Academy of Sciences (SB RAS), Novosibirsk (www.iimed.ru)

DETAILS
Bio
Ragino, Yuliya Igorevna PhD and ScD in medicine, Main Accreditation Commission (VAK) professor, Russian Academy of Sciences (RAS) professor, corresponding member of the RAS, head of the Institute of Internal and Preventive Medicine – a branch of a federal publicly funded scientific institution, the federal research center Institute of Cytology and Genetics, the Siberian Branch of the RAS (IIPM – a branch of the ICG SB RAS) Ragino Yu.I. is an expert in the fields of medical biochemistry and pathophysiology and an author or coauthor of more than 350 scientific publications, including 8 books, 8 patents of the Russian Federation, and 2 patents of the Eurasian Patent Organization. In the Russian Scientific Citation Index (RSCI): 392 publications, 1659 citations, h-index: 21. In Scopus: 104 publications, 703 citations, h-index: 8. In the Web of Science: 120 publications, 579 citations, h-index: 7. In 1994, she graduated from Novosibirsk State Medical University and has worked at the Institute of Internal and Preventive Medicine since 1995. In 1997, she defended a PhD dissertation, and in 2002, an ScD dissertation. The main basic-research accomplishments of Ragino Yu.I.: A study on the key biochemical markers and mechanisms of formation of unstable atherosclerotic plaques and of their various types in atherosclerosis. The development of methods for early biochemical diagnosis of atherosclerosis and risk assessment of acute coronary syndrome. Conceptualization of the one-directionality of highly atherogenic changes of oxidation-modified and structurally altered lipoproteins of the blood, including small high-density atherogenic subfractions of lipoproteins, in clinically significant atherosclerosis and in the presence of its major risk factors; in this regard, novel evaluation criteria of pharmacotherapy effectiveness have been proposed. Research into atherogenic properties of oxidized proteins and their role in atherogenesis. Creation and investigation of experimental animal models (in vitro, in vivo), new lipid-containing coordination compounds

Event Schedule

Nov 27
10:00 - 19:00
MATURITY ONSET DIABETES OF THE YOUNG (MODY): MOLECULAR GENETIC DETERMINANTS AND A PERSONALIZED APPROACH TO PATIENT MANAGEMENT
This one day course on Maturity Onset Diabetes of the Young (MODY) is aimed at clinicians recognize and treat patients with MODY. It will focus on the current practices and new developments in the management of monogenic diabetes. The program will include plenary lectures on major topics delivered by team of experts. Separate small group case-based discussions will focus on key themes. Time UTC/GMT+7

Instructions for Authors

Writing and submitting your abstract

Please follow the guidance below when writing and submitting your abstract

Aim: state background and specific objective of study
Methods: shortly describe methods used
Results: summarize results obtained
Conclusions: state conclusions reached
• Standard abbreviations may be used.

Presentation type – please choose from one of the following:
• Oral presentation
• E-Poster presentation


Abstract title – Limited to 25 words in Sentence Structure
Abstract text – Limited to 250 words (Please Note: Word count is not affected when graphs/tables/images are added).
Abstract topic – Abstracts must be allocated to a specific topic for the Scientific Program. Please choose from the list of topics.

Declaration of Consent to Publication

• I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
• Submission of the abstract constitutes my consent to publication (e.g. congress website, programmes, other promotions, etc.)
• The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content”) provided to BRE2020. The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights.
• The Abstract Submitter grants the BRE2020 a royalty-free, perpetual, irrevocable nonexclusive license to use, publish and display the Content.
• I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.

BRE2020 embargo policy

The findings described in an abstract submitted for presentation must contain some new data. The abstract, in its entirety, may not have been published or presented elsewhere prior to their presentation at the BRE2020.

Venue, Travel and Accommodation

23 Morskoy Prospekt, Akademgorodok, 630090, Novosibirsk, Russia

175/1 Borisa Bogatkova Street, 630089, Novosibirsk, Russia

The Institute was founded in 1981 (https://iimed.ru/eng). The objective and subject area of the Institute of Internal and Preventive Medicine – a branch of a federal publicly funded scientific institution, the federal research center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences (IIPM – a branch of the ICG SB RAS), are basic, exploratory, and applied scientific studies in priority areas of molecular medicine and human genetics as well as safeguarding and improvement of human health, the development of health care and medical science, and preparation of high-skill specialists in science and medicine. The main research areas of the IIPM – a branch of the ICG SB RAS: Studies on molecular biological, organism level, and populational patterns of development of major internal diseases in the Siberian population and designing a scientific basis for their prevention, diagnosis, and treatment; Research on the prevalence of major internal diseases, morbidity patterns, and causes of death in the population of Siberia, Far East, and Far North in relation to internal medicine diseases considering the specific features of climatic-geographic, social, and hygienic factors; Investigation of the clinical features and pathogenesis of the major therapeutic diseases taking into account heredity and environmental factors; The development of the scientific basis for organization of specialty medical care of the Siberian, Far Eastern, and Far Northern population. Affiliated Research Centers City Center for the Prevention and Treatment of Thromboses City Center for Dementia Control City Center of the Stroke Registry City Lipid Center The Clinic at the Institute specializes in the treatment of patients with cardiovascular, gastrointestinal, endocrine, and genetic diseases. The Clinic includes 3 in-patient departments (internal medicine, gastroenterology, and endocrinology), a primary care research-consulting department, a department of clinical-biochemical and molecular genetic diagnostics, a department of functional diagnostics, an X-ray imaging facility, and a comprehensive center of medical prophylaxis.

Visa

Visa
Dear foreign guests!
According to the requirements of the Federal Migration Service (FMS) and the Russian legislation for foreign colleagues to participate in the «Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine» it is necessary to make a humanitarian visa, which includes scientific and technical visa. Participation in the conference of foreign participants with a tourist or business visa is prohibited by the FMS rules.
Humanitarian visa is prepared on the basis of an invitation letter, which is made by the conference organizing committee in the Ministry of Foreign Affairs (MFA) of Russia.

Visa invitation is prepared for free in 2 weeks for residents of USA, China, Japan, Austria, Belgium,Bulgaria, Hungary, Germany, Denmark, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg,Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Finland, France, Croatia, Czech Republic, Switzerland, Sweden, Estonia.
For invitation letter preparation please send e-mail with the subject “Visa for BRE2020” to the organizing committee: bre-2020@mail.ru. The letter should contain following data:
  • Passport copy (the page with photo) (PDF or any graphics format)
  • Compete office address
  • Position
  • Post code
  • Fax number
  • Phone number
  • The name of the city where the visa have to be prepared (in the Russian consulate in the country).
For residents of other countries (not included in the list of the countries listed above), the cost of processing the visa invitation is 800 rubles. Turnaround time – 1, 5 months. Payment will be carried out on arrival at the conference (at the registration).
IMPORTANT: for residents of these countries for preparation of visa invitations, along with the rest of the documents listed above, it is necessary to send a complete copy of your passport (including blank pages).
For questions regarding the visa invitations, please contact to the organizing committee: bre-2020@mail.ru

Recommended hotels

Hotel/Accommodation Address Description
Gold Valley (Zolotaya dolina) Ilyicha st. 10, 630090, Novosibirsk, Russia The hotel "Golden Valley" is glad to offer you single and double standard rooms, suite and semi-suite. We also have special offers for groups and corporate clients. We aim to make your staying comfortable and affordable. 0,5 km from venue
Domina Novosibirsk Novosibirsk, Lenina str., 26, 630112, Novosibirsk, Russia The stylish Domina Novosibirsk, with its European approach to work and respite, is located in the very heart of Novosibirsk. From the windows of the 11-storey building a panorama opens upon the historic areas of Novosibirsk and the “City” commercial distr

Sponsors and Partners

The event is held with the financial support of the Russian Foundation for Basic Research.

Russian Foundation for Basic Research (RFBR) was created by decree #426 of the President of the Russian Federation “On urgent measures for preserving scientific and technological potential of the Russian Federation” and is a self-governed state nonprofit organisation in the form of a federal organisation controlled by the Government of the Russian Federation. Being a representative of the state, the Foundation provides targeted diversified support to leading groups of scientists regardless of the organisation they represent. Support of initiative scientific research in all the principal directions of fundamental science is carried out strictly on a competition basis after a comprehensive evaluation.

In its chartered activities RFBR relies on the following principles:
- openness — announcements of competitions and their results, the Foundation's decisions on financing projects and events, and also other materials are published in paper editions and online;
- targeted financing of groups of scientists (and not organisations as a whole), which perform projects approved by the Foundation experts;
- giving the scientists freedom of choice of subjects in all fields of natural sciences and humanities, of methods of conducting fundamental research, and of creating research groups.

For information regarding sponsorship and exhibition opportunities, please click here.

BASIC RESEARCH IN ENDOCRINOLOGY: A MODERN STRATEGY FOR THE DEVELOPMENT AND TECHNOLOGIES OF PERSONALIZED MEDICINE: Plenary session

26 November 2020

8:30-9:00

Registration for the conference

Participants are connected to the webcast

UTC/GMT +7

9:00

Start of webcasting from Conference Hall of Institute of Cytology and Genetics (ICG), Siberian Branch of Russian Academy of Sciences (SB RAS)

Hall No. 1: https://events.webinar.ru/medcongress/261120w1

Plenary session

9:00-9:15

Conference opening

Voevoda M.I., director of Federal Research Center of Fundamental and Translational Medicine (FRC FTM), member of Russian Academy of Sciences (RAS)

Kochetov A.V., director of ICG SB RAS, corresponding member of RAS

Ragino Yu.I., head of Institute of Internal and Preventive Medicine (IIPM) – branch of ICG SB RAS, corresponding member of RAS

9:15-10:00

Plenary presentation

O.D. Rymar, M.D., Ph.D., Sc.D. (Novosibirsk)

Epidemiological and clinical-genetic research on endocrine pathologies at the IIPM – a branch of the ICG SB RAS

Conference Hall of ICG SB RAS

Hall No. 1

https://events.webinar.ru/medcongress/261120w1

House of Scientists (Dom Uchenykh) SB RAS

Hall No. 2 https://events.webinar.ru/medcongress/261120w2

BASIC RESEARCH IN ENDOCRINOLOGY: A MODERN STRATEGY FOR THE DEVELOPMENT AND TECHNOLOGIES OF PERSONALIZED MEDICINE: Specialty sessions

10:00-11:00

Scientific symposium

“Endocrine cardiology”

Chairpersons: L.A. Ruiatkina, M.D., Ph.D., Sc.D., professor (Novosibirsk); O.D. Rymar, M.D., Ph.D., Sc.D. (Novosibirsk)

1. Ruiatkin D.S., Ruiatkina L.A., Iskhakova I.S. (Novosibirsk) “Lipoglucotoxicity as a subtype of insulin resistance in postmenopausal women with cardiometabolic risks” (10:00-10:15)

2. Tsygankova O.V., Ragino Yu.I. (Novosibirsk) “Parameters of coronary artery calcification in patients with pre-existing coronary heart disease, depending on age and sex hormone levels” (10:15-10:30)

3. Malyutina S.K., Shapkina M.Yu. (Novosibirsk) “Diabetes mellitus and atrial fibrillation according to data from cross-sectional and cohort studies” (10:30-10:45)

4. Shapkina M.Yu., Mazdorova E.V., Avdeeva E.M., Malyutina S.K. (Novosibirsk) “ Metabolic factors and long-term risk of atrial fibrillation in a population cohort” (10:53-11:00)

5. Titarenko A.V., Shishkin S.V., Shcherbakova L.V., Malyutina S.K. (Novosibirsk) “The relation between metabolic risk factors and indicators of cognitive functions in the elderly population” (10:45-10:52)

Scientific symposium

“Problems of the prevalence, pathogenesis, and treatment of obesity”

Chair: S.V. Mustafina, M.D., Ph.D., Sc.D. (Novosibirsk)

1. Mustafina S.V. (Novosibirsk) “Metabolic phenotypes of obesity and its outcomes according to data from 14-year prospective follow-up” (10:00-10:20)

2. Ryabikov A.N., Shakhmatov S.G., Yasyukevich N.V., Malyutina S.K. (Novosibirsk) “Metabolic-dysfunction-associated fatty liver disease (MAFLD): determinants and prognosis” (10:20-10:40)

3. Denisova D.V. (Novosibirsk) “Overweight in adolescents: 30-year trends” (10:40-11:00)

11:00-11:30

Break

Advertising presentation

O.V. Tsygankova, M.D., Ph.D., Sc.D., professor in the Department of Emergency Medicine with Endocrinology and Occupational Diseases, Faculty for Advanced Training and Professional Retraining of Physicians at Novosibirsk State Medical University; Senior Research Associate at the IIPM – a branch of the ICG SB RAS, Novosibirsk, (Astra Zeneca), “Diabetes mellitus and cardiovascular diseases. A clinical medley: divide and mix”

11:30-13:00

Scientific symposium

“Diseases of the thyroid. Possible preventive and therapeutic measures”

Chairpersons: V.V. Fadeev, corresponding member of RAS, M.D., Ph.D., Sc.D., professor (Moscow); O.D. Rymar, M.D., Ph.D., Sc.D. (Novosibirsk)

1. Serikbaeva A.A. (Kazakhstan) “Hypothyroidism: a relation with indices of essential and toxic microelements in women of reproductive age in the Aral Sea region (Kazakhstan Republic)” (11:30-12:00)

2. Ruiatkina L.A., Ruiatkin D.S., Iskhakova I.S. (Novosibirsk) “Subclinical hypothyroidism and cardiometabolic risks in postmenopausal women: is there a link?” (12:00-12:30)

3. Fadeev V.V. (Moscow) “Problems of hypothyroidism replacement therapy in modern clinical practice” (12:30-13:00)

Scientific symposium

“Modern technologies for the treatment of diabetes mellitus and its complications” Chairpersons: V.V. Klimontov, M.D., Ph.D., Sc.D., professor (Novosibirsk); Y.G. Samoilova, M.D., Ph.D., Sc.D., professor (Tomsk)

1. Klimontov V.V. (Novosibirsk) “Analysis of ‘big data’ in diabetology: from pathogenesis research to new therapeutic technologies” (11:30-11:50)

2. Semenova Yu.F. (Novosibirsk) “Fluctuations of glucose levels in healthy people: do we know everything?” (11:50-12:10)

3. Samoilova Y.G. , Layman O.P., Tonkikh O.S. (Tomsk) “New methods of diagnosing cognitive impairments in diabetes mellitus by modern neuroimaging methods: for whom should we choose which method?” (12:10-12:30)

4. Matveeva M.V. (Tomsk) “Contrast and noncontrast MRI of the brain and glycemic variability in type 1 and 2 diabetes mellitus” (12:30-12:50)

10-minute discussion

13:00-13:30

Break

Advertising presentation (13:10-13:30)

N.A. Petunina, corresponding member of RAS, M.D., Ph.D., Sc.D., professor, chair of the Department of Endocrinology and Diabetology at I.M. Sechenov First Moscow State Medical University, Moscow (Astellas Pharma), “ The role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus”

13:30-15:00

Scientific symposium

“Hormonally active tumors of the pituitary. Modern therapeutic methods”

Chairpersons: G.R. Vagapova, M.D., Ph.D., Sc.D., professor (Kazan); S.A. Dogadin, M.D., Ph.D., Sc.D., professor (Krasnoyarsk)

1. Dogadin S.A., Dudina M.A., Savchenko A.A. (Krasnoyarsk) “Acromegaly: does the effectiveness of treatment with somatostatin analogs affect immune-status indicators?” (13:30-13:55)

2. Grineva E.N. (St. Petersburg) “Current options for differential diagnosis of ACTH-dependent hypercortisolism” (13:55-14:20)

3. Vagapova G.R. (Kazan) “Prolactinomas. A personalized approach to treatment” (14:20-14:45)

4. Ivanoshchuk D.E. (Novosibirsk) “Polymorphism of genes SOX2, SOX3, HESX1, and OTX2 involved in the formation of the hypothalamic-pituitary axis” (14:45-15:00)

Scientific symposium

“Metabolomic research in endocrinology”

Chairpersons: A.V. Lisitsa, M.D., Ph.D., Sc.D., member of RAS (Moscow); T.V. Saprina, M.D., Ph.D., Sc.D., professor (Tomsk)

1. Lisitsa A.V. (Moscow) “The use of web tool ScanBious Text Mining to decipher semantic networks of the metabolites associated with obesity” (13:30-13:50)

2. Valeeva F.V., Khasanova K.B. (Kazan) “The molecular basis for early disorders of carbohydrate metabolism” (13:50-14:10)

3. Musina N.N., Saprina T.V. (Tomsk) “The structure of ferrokinetic disorders and anemia in diabetes mellitus, and features of a differential diagnostic algorithm” (14:10-14:30)

4. Musina N.N., Saprina T.V. (Tomsk) “Specific features of ferrokinetics and inflammatory status in patients with concurrent type 1 or 2 diabetes mellitus and dyslipidemia” (14:30-14:50)

5. Shramko V.S. (Novosibirsk) “A study on fatty-acid concentrations and their association with lipid metabolism indicators and lipoprotein-associated phospholipase A2 in patients with visceral obesity” (14:50-15:00)

15:00-15:30

Break

Advertising presentation (15:00-15:30)

V.V. Klimontov, M.D., Ph.D., Sc.D., scientific deputy head of the branch and a head of the Laboratory of Endocrinology at the Research Institute of Clinical and Experimental Lymphology – a branch of the ICG SB RAS, Novosibirsk, (Astra Zeneca), “Diabetes mellitus and chronic kidney disease: achievements, unresolved problems, and treatment prospects”

15:30-17:00

Scientific symposium

“An interdisciplinary approach to the diagnosis and treatment of metabolic syndrome”

Chairpersons: G.I. Simonova, M.D., Ph.D., Sc.D., professor (Novosibirsk); S.V. Mustafina, M.D., Ph.D., Sc.D. (Novosibirsk)

Section description: Insulin resistance in various disorders, outcomes of metabolic syndrome, and modern preventive and therapeutic methods.

1. Ragino Yu.I. (Novosibirsk) “The role of vascular calcification in the stability and instability of atherosclerotic plaques in patients with metabolic syndrome” (15:30-15:55)

2. Simonova G.I. (Novosibirsk) “The risk of cardiovascular death in metabolic syndrome according to a prospective study” (15:55-16:20)

3. Bondar I.A. (Novosibirsk) “The prevalence, prevention, and treatment of prediabetes in metabolic syndrome” (16:20-16:45)

4. Benimetskaya K.S. (Novosibirsk) “The relation of proprotein convertase subtilisin/kexin type 9 (PCSK9) with carbohydrate metabolism” (16:45-17:00)

Scientific symposium

“Genomic research in endocrinology”

Chairpersons: M.I. Voevoda, M.D., Ph.D., Sc.D., member of RAS (Novosibirsk); V.N. Maksimov, M.D., Ph.D., Sc.D., professor (Novosibirsk)

1. Maksimov V.N. (Novosibirsk) “Potentially fatal cardiac complications during endocrine pathology. Benefits of genomic findings for their prediction” (15:30-15:55)

2. Shakhtshneider E.V. (Novosibirsk) “Transcription factors responsible for the regulation of carbohydrate and lipid metabolic pathways” (15:55-16:15)

3. Orlov P.S. (Novosibirsk)CEL gene polymorphism in patients with concurrent hyperglycemia and dyslipidemia (16:15-16:30)

4. Semaev S.E. (Novosibirsk) “Genetic risk calculators for assessing the risk of CVD in the presence of endocrine pathology” (16:30-16:45)

5. Ivanova A.A. (Novosibirsk) “Endocrine pathologies and molecular genetic markers of sudden cardiac death: is there a connection? (16:45-17:00)

17:00-17:30

10-minute break

Advertising presentation (17-10:17-30)

G.R. Galstyan, M.D., Ph.D., Sc.D., professor, chair of the Diabetic Foot Department at the National Medical Research Center of Endocrinology, Moscow, (Novo Nordisk), “Cardiovascular safety and diabetes mellitus”

17:30-18:30

Scientific symposium

“Monogenic types of diabetes mellitus”

Chairpersons: M.I. Voevoda, M.D., Ph.D., Sc.D., member of RAS; O.D. Rymar, M.D., Ph.D., Sc.D.; A.K. Ovsyannikova, M.D., Ph.D. (Novosibirsk)

Andrew Hattersley, professor of Molecular Medicine University of Exeter Medical School (United Kingdom)

“Overview Lecture about monogenic diabetes - Problems around diagnosis/misdiagnosis”

18:30-19:00

Symposium “Reproductive health”

N.M. Pasman (Novosibirsk), M.D., Ph.D., Sc.D., professor

“PCOS is an interdisciplinary problem with multiple risks. A team approach to patient management”

19:00-19:20

Final exam (test assignments). Passing grade: ≥70% of correct answers.

MATURITY ONSET DIABETES OF THE YOUNG (MODY): MOLECULAR GENETIC DETERMINANTS AND A PERSONALIZED APPROACH TO TREATMENT: Educational course for physicians

27 November 2020

Educational course for physicians

MATURITY ONSET DIABETES OF THE YOUNG (MODY):
MOLECULAR GENETIC DETERMINANTS AND A PERSONALIZED APPROACH TO TREATMENT

9:00-10:00

UTC/GMT+7

Registration of participants

Start of webcasting from Conference Hall of IIPM – branch of ICG SB RAS

Hall No. 1: https://events.webinar.ru/medcongress/271120w1

10:00-10:10

Opening of the educational course

10:10-10:50

Lecture of V.N. Maksimov, M.D., Ph.D., Sc.D., professor (Novosibirsk) “Genomics in personalized medicine”

11:00-11:30

Lecture of A.K. Ovsyannikova, M.D., Ph.D. (Novosibirsk) “A personalized approach to the diagnosis of MODY-type diabetes”

11:30-12:10

Break

Advertising presentation

O.Y. Shabelnikova, M.D., Ph.D., chair of the Endocrinology Department at Novosibirsk Regional Clinical Hospital, head of the Regional Endocrinology Center, and Chief Endocrinologist of Novosibirsk Oblast, “The patient with type 2 diabetes mellitus and chronic kidney disease from the standpoint of an endocrinologist,” Novosibirsk (Astellas Pharma)

12:10-13:30

Lecture of M.A. Kovarenko, M.D., Ph.D. (Novosibirsk) “Diagnostic dilemmas of diabetes mellitus in children and young adults” (12:10-12:45)

Lecture of O.D. Rymar, M.D., Ph.D., Sc.D.; A.K. Ovsyannikova, M.D., Ph.D. (Novosibirsk) “A personalized approach to MODY treatment: presentation of clinical cases” (12:45-13:20)

Discussion

13:30-14:00

Break

14:00-15:30

Lecture of A.K. Ovsyannikova, M.D., Ph.D. (Novosibirsk) “The course of common MODY forms (GCK-MODY and HNF1A-MODY) in the Siberian region: data from dynamic observation” (14:00-14:40)

Lecture of Yu.A. Dolinskaya (Novosibirsk) “Specific features of the GCK-MODY course: presentation of a clinical case” (14:40-15:20)

Discussion

15:30-15:45

Break

15:45-17:15

Lecture of N.A. Zubkova, M.D., Ph.D. (Moscow) “Diagnosis and treatment of MODY during pregnancy” (15:45-16:30)

Lecture of Dr. Alice Hughes, Wellcome Trust Funded Clinical Academic Training, PhD Fellow, University of Exeter Medical School (UK) “Prenatal testing in GCK-MODY pregnancies: an opportunity for precision medicine to make an impact in obstetric medical care” (16:30-17:15)

17:15-17:30

Break

17:30-18:00

Lecture of A.K. Ovsyannikova, M.D., Ph.D. (Novosibirsk) “Rare subtypes of monogenic types of diabetes mellitus: presentation of clinical cases”

18:00-18:30

Lecture of E.V. Shakhtshneider, M.D., Ph.D. (Novosibirsk) “Cascade genetic testing for hereditary types of diabetes mellitus”

18-30:19-00

Final exam (test assignments). Passing grade: ≥70% of correct answers.

Concluding procedures of the educational course

* This event is managed by external organizers. Sciforum is not responsible for the content posted on this website.
Top